PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411, Tartu, Estonia. anneli.uuskula@ut.ee.\', \'Department of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411, Tartu, Estonia.\', \'Icosagen Cell Factory, Eerika tee 1, Kambja vald, 61713, Tartu county, Estonia.\', \'Clinic of Oncology, North-Estonian Medical Centre, Sütiste Rd 19, 13419, Tallinn, Estonia.\', \'ChemiPharm, Tänassilma road 11, 76406, Tänassilma, Harju county, Estonia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-022-06039-9
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 35101094
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • Cluster randomised, controlled, triple-blind trial assessing the efficacy of intranasally administered virus-neutralising bovine colostrum supplement in preventing SARS-CoV-2 infection in household contacts of SARS-CoV-2-positive individuals: a study protocol.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all